TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

被引：15

作者：

Hiwase, Devendra ^{[1
,2
,3
,4
,5
]}

Hahn, Christopher ^{[4
,5
,7
]}

Tran, Elizabeth Ngoc Hoa ^{[2
,3
]}

Chhetri, Rakchha ^{[1
,2
,3
]}

Baranwal, Anmol ^{[6
]}

Al-Kali, Aref ^{[6
]}

Sharplin, Kirsty ^{[1
]}

Ladon, Dariusz ^{[7
]}

Hollins, Rachel ^{[7
]}

Greipp, Patricia ^{[8
]}

Kutyna, Monika ^{[1
,2
,3
]}

Alkhateeb, Hassan ^{[6
]}

Badar, Talha ^{[9
]}

Wang, Paul ^{[10
]}

Ross, David M. ^{[1
,2
,3
,4
,5
]}

Singhal, Deepak ^{[1
,2
]}

Shanmuganathan, Naranie ^{[1
,2
]}

Bardy, Peter ^{[1
]}

Beligaswatte, Ashanka ^{[1
]}

Yeung, David ^{[1
,2
]}

Litzow, Mark R. ^{[6
]}

Mangaonkar, Abhishek ^{[6
]}

Giri, Pratyush ^{[1
]}

Lee, Cindy ^{[1
]}

Yong, Angie ^{[1
]}

Horvath, Noemi ^{[1
]}

Singhal, Nimit ^{[1
]}

Gowda, Raghu ^{[1
]}

Hogan, William ^{[6
]}

Gangat, Naseema ^{[6
]}

Patnaik, Mrinal ^{[6
]}

Begna, Kebede ^{[6
]}

Tiong, Ing S. ^{[11
,12
]}

Wei, Andrew ^{[11
,12
]}

Kumar, Sharad ^{[4
,5
]}

Brown, Anna ^{[4
,5
,7
]}

Scott, Hamish ^{[4
,5
,7
]}

Thomas, Daniel ^{[1
,2
,3
]}

Kok, Chung H. ^{[2
,3
]}

Tefferi, Ayalew ^{[6
]}

Shah, Mithun Vinod

机构：

[1] Royal Adelaide Hosp, Cent Adelaide Local Hlth Network, Dept Haematol, Adelaide, SA, Australia

[2] South Australian Hlth & Med Res Inst SAHMRI, Precis Med Theme, Adelaide, SA, Australia

[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia

[4] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia

[5] SA Pathol, Adelaide, SA, Australia

[6] Mayo Clin Rochester, Div Hematol, Rochester, MN 55906 USA

[7] SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia

[8] Mayo Clin Rochester, Lab Med & Pathol, Rochester, MN 55906 USA

[9] Mayo Clin Jacksonville, Dept Hematol Oncol, Jacksonville, FL USA

[10] SA Pathol, ACRF Canc Genom Facil, Adelaide, SA, Australia

[11] Alfred Hosp, Dept Haematol, Melbourne, Vic, Australia

[12] Monash Univ, Melbourne, Vic, Australia

来源：

BLOOD | 2023年 / 141卷 / 09期

基金：

澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;

关键词：

D O I：

10.1182/blood.2022018236

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1087 / 1091

页数：5

共 50 条

[31] TP53 germline mutations occur in acute myeloid leukemia and are associated with therapy-related cases following ionizing radiation
Zebisch, A.
Lal, R.
Mueller, M.
Lind, K.
Sill, H.
WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S385 - S386
[32] RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7
Side, LE
Curtiss, NP
Teel, K
Kratz, C
Wang, PW
Larson, RA
Le Beau, MM
Shannon, KM
GENES CHROMOSOMES & CANCER, 2004, 39 (03): : 217 - 223
[33] Isolated Orbital Myeloid Sarcoma as a Therapy-related Myeloid Neoplasm
Ishiguro, Kazuya
Takahashi, Tohru
INTERNAL MEDICINE, 2019, 58 (07) : 1045 - 1046
[34] Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Zak, Taylor
Sukhanova, Madina
Gao, Juehua
Fu, Lucy
Chen, Yi-Hua
Chen, Qing Ching
Behdad, Amir
Tariq, Hamza
LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1691 - 1697
[35] TP53 mutation screening for patients at risk of myeloid malignancy
Mukherjee, Devdeep
Lawal, Rialnat A.
Fitzhugh, Courtney D.
Hourigan, Christopher S.
Dillon, Laura W.
LEUKEMIA, 2024, 38 (07) : 1604 - 1608
[36] Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
Sperling, Adam S.
Guerra, Veronica A.
Kennedy, James A.
Yan, Yuanqing
Hsu, Joanne, I
Wang, Feng
Nguyen, Andrew T.
Miller, Peter G.
McConkey, Marie E.
Barrios, Vanessa A. Quevedo
Furudate, Ken
Zhang, Linda
Kanagal-Shamanna, Rashmi
Zhang, Jianhua
Little, Latasha
Gumbs, Curtis
Daver, Naval
DiNardo, Courtney D.
Kadia, Tapan
Ravandi, Farhad
Kantarjian, Hagop
Garcia-Manero, Guillermo
Futreal, P. Andrew
Ebert, Benjamin L.
Takahashi, Koichi
BLOOD, 2022, 140 (16) : 1753 - 1763
[37] Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
Link, Daniel C.
Schuettpelz, Laura G.
Shen, Dong
Wang, Jinling
Walter, Matthew J.
Kulkarni, Shashikant
Payton, Jacqueline E.
Ivanovich, Jennifer
Goodfellow, Paul J.
Le Beau, Michelle
Koboldt, Daniel C.
Dooling, David J.
Fulton, Robert S.
Bender, R. Hugh F.
Fulton, Lucinda L.
Delehaunty, Kimberly D.
Fronick, Catrina C.
Appelbaum, Elizabeth L.
Schmidt, Heather
Abbott, Rachel
O'Laughlin, Michelle
Chen, Ken
McLellan, Michael D.
Varghese, Nobish
Nagarajan, Rakesh
Heath, Sharon
Graubert, Timothy A.
Ding, Li
Ley, Timothy J.
Zambetti, Gerard P.
Wilson, Richard K.
Mardis, Elaine R.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (15): : 1568 - 1576
[38] Molecular mechanism in prostate cancer with TP53 mutation
Hu, B.
Liu, H.
Zhang, Y.
Wang, H.
ANNALS OF ONCOLOGY, 2022, 33 : S1606 - S1606
[39] Estimating Therapy-Related Myeloid Neoplasm Risks in the US
Radivoyevitch, Tomas
Sachs, Rainer K.
Gale, Robert Peter
Sekeres, Mikkael A.
Maciejewski, Jaroslaw P.
Kalaycio, Matt
Mukherjee, Sudipto
BLOOD, 2014, 124 (21)
[40] Older Age and TP53 Mutations Are Predictors for the Development of Therapy-Related Myeloid Neoplasms in Adults Undergoing Frontline Therapy for Acute Lymphoblastic Leukemia
Azevedo, Roberta Santos
Kantarjian, Hagop M.
Takahashi, Koichi
Nasnas, Cedric Christophe
Loghavi, Sanam
Jain, Nitin
Haddad, Fadi G.
Senapati, Jayastu
Issa, Ghayas C.
Abbas, Hussein A.
Kadia, Tapan M.
Chien, Kelly S.
Montalban-Bravo, Guillermo
Garris, Rebecca
Ravandi, Farhad
Jabbour, Elias
Short, Nicholas J.
BLOOD, 2024, 144 : 728 - 729

← 1 2 3 4 5 →